Topic 6 - Microbiology A2, Immunity and Forensics
- Syllabus
- 2021
- Topic
- —
- Level
- A2
Microbial culture requires sterile media, equipment and technique so that the organism being studied is not outcompeted or confused with contaminants. Aseptic handling protects the sample, the investigator and the environment.
Sterilise media and apparatus, disinfect the work area, minimise exposure of plates or broths, and label controls. Compare growth with a negative control to detect contamination.
If a plate exposed briefly during inoculation grows colonies outside the intended streak, those colonies may be contaminants rather than evidence about the tested organism.
A clear plate does not prove sterility, and opening a culture outside controlled conditions can create a safety hazard. Use the required containment and disposal procedure.
No single measurement equals 'growth' in every culture. Choose whether the question needs total cells, viable cells, biomass or an optical proxy, then calibrate and repeat the method over time.
| Method | What is measured | Strength | Limitation |
|---|---|---|---|
| Direct cell count | Cells in a known haemocytometer volume | Fast total count | Live and dead cells may be indistinguishable |
| Dilution plating | Colonies from a known diluted volume | Estimates viable colony-forming units | Clumps form one colony; requires incubation |
| Dry mass | Mass after harvesting and drying cells to constant mass | Useful for dense or filamentous cultures | Destructive and insensitive at low biomass |
| Turbidity/optical density | Light absorbance or transmission | Rapid repeated readings | Includes dead cells and needs a calibration range |
For viable count, make serial dilutions aseptically, spread a known volume, incubate consistently and use a countable plate. CFU per cm3=colonies/(dilution×volume plated in cm3). Include dilution and units in the answer.
A colony may arise from more than one attached cell, so report colony-forming units rather than exact cells. Turbidity is not automatically viable count, and one endpoint cannot establish a growth rate.
A closed culture shows lag, exponential, stationary and death phases. Plot log10 number of living cells against time: lag reflects adjustment; exponential phase has a near-constant division rate; stationary phase has births approximately balancing deaths; death phase has falling viable count.
| Phase | Population pattern | Main explanation |
|---|---|---|
| Lag | Little net increase | Cells synthesise enzymes and adjust to conditions |
| Exponential | Straight rising section on a log-count graph | Resources are abundant and cells divide at a near-constant per-capita rate |
| Stationary | Plateau | Nutrients/oxygen become limiting and waste or pH change inhibits growth |
| Death | Viable count decreases | Death exceeds division under deteriorating conditions |
During the exponential phase, k=0.301tlog10Nt−log10N0, where N0 and Nt are living-cell numbers and t is elapsed time. The constant k is generations per unit time because log102≈0.301. Generation time is 1/k in the matching time unit.
If N0=900, Nt=14000 after 2 h, then k=(4.146−2.954)/(0.301×2)=1.98 generations h−1 to three significant figures.
Calculate k only across the exponential region and use viable-cell numbers. Stationary phase does not mean every cell has stopped metabolising or that all cells are dead.
Create a time series from an approved non-pathogenic microorganism in liquid medium, changing one condition only if a comparison is required. Turbidity gives rapid repeated measurements; viable counts can check whether cloudiness represents living cells.
Use only the organism, temperature and containment authorised by the local risk assessment; keep cultures closed except for aseptic sampling, wear specified protection, disinfect spills and sterilise cultures and contaminated materials before disposal. Minimise culture volume and exposure consistent with reliable results.
A colorimeter records turbidity, including dead cells and clumps. Do not reopen incubated cultures outside the approved procedure or infer a rate from one final reading.
Bacteria are living prokaryotic cells with cell-surface membrane, cytoplasm, 70S ribosomes, circular DNA and usually a murein wall. Viruses are acellular: nucleic acid is enclosed by a protein capsid, sometimes within a host-derived lipid envelope, and replication requires a host cell.
| Particle/cell | Nucleic acid | Capsid shape or special structure | Envelope |
|---|---|---|---|
| Bacterium | Circular double-stranded DNA; may have plasmids | No capsid; cell wall surrounds membrane | No viral envelope |
| Ebola virus | Single-stranded RNA | Helical nucleocapsid in a filamentous particle | Lipid envelope with glycoproteins |
| Tobacco mosaic virus (TMV) | Single-stranded RNA | Helical rod-shaped capsid | None |
| HIV | Two copies of single-stranded RNA | Capsid containing reverse transcriptase | Lipid envelope with attachment glycoproteins |
| Lambda phage | Double-stranded DNA | Head capsid plus tail and attachment fibres | No lipid envelope |
In a lytic infection, the viral genome directs synthesis and assembly of new particles, followed by host-cell lysis and release. In latency, viral genetic material persists with little or no particle production—often integrated into host DNA—and can later reactivate into productive infection.
A capsid is protein; an envelope is an additional lipid membrane, so not every virus has both. Viral latency is not elimination, and antibiotics targeting bacterial ribosomes or walls do not act on viruses.
Tuberculosis begins when inhaled Mycobacteriumtuberculosis reaches alveoli and is engulfed by macrophages. The bacteria can survive inside these cells, including by resisting normal phagosome digestion. Immune cells form tubercles that may contain a latent infection; reactivation damages lung tissue and can spread through blood to other organs.
Active pulmonary TB can cause persistent cough, blood in sputum, fever, night sweats and weight loss. Gas-exchange damage and disseminated infection can become fatal, especially when immunity is weak.
HIV envelope protein binds CD4 and co-receptors on T helper cells. Viral RNA enters; reverse transcriptase makes DNA, integrase inserts it into host DNA, and the provirus may remain latent or direct new virus production. Budding and immune destruction progressively reduce functional T helper cells.
Loss of T helper signalling weakens activation of B cells, killer T cells and macrophages. Advanced immunodeficiency allows opportunistic infections and cancers; these consequences, rather than one immediate effect of viral entry, can cause death.
Exposure, infection, latency and symptomatic disease are different states. HIV does not directly cause TB, but its depletion of T helper cells makes latent or new TB harder to contain.
Pathogens can enter through broken skin, food and drink, the respiratory tract or mucosal surfaces. Skin, clotting, gut flora, stomach acid and lysozyme reduce entry or survival before a specific immune response is needed.
Each barrier uses a different mechanism: intact skin blocks access, a clot seals damage, resident microbes compete, acid harms swallowed pathogens and lysozyme damages bacterial walls.
A cut bypasses the skin barrier, but clotting limits further entry; a swallowed pathogen must also survive stomach acid and compete with gut flora before reaching intestinal tissue.
A barrier lowers risk rather than guaranteeing protection. Do not confuse lysozyme’s bacterial-wall action with a general antiviral response.
Non-specific responses act against many pathogens and begin rapidly. Histamine-driven inflammation changes blood flow and capillary permeability; interferons limit viral replication; phagocytes engulf and digest foreign material.
During phagocytosis, a phagocyte recognises non-self antigens, encloses the pathogen in a vacuole, lysosomes fuse with it and digestive enzymes break it down. Antigen presentation can then initiate a specific response.
A splinter can trigger local swelling as histamine recruits fluid and phagocytes. A virus-infected cell can release interferons that warn nearby cells and activate immune defences.
Non-specific does not mean unregulated or ineffective, and it is not the same as antibody specificity. Keep inflammation, interferon action and phagocytosis as distinct mechanisms.
An antigen is a molecule recognised as non-self by a specific lymphocyte receptor or antibody. Each antibody has variable binding sites complementary to one antigenic epitope; its constant region interacts with other immune components.
Antibody binding can neutralise toxins or attachment sites, agglutinate pathogens and opsonise their surfaces. Macrophages then bind antibody-tagged material more readily and remove it by phagocytosis.
Antibodies are secreted by plasma cells, not macrophages or T cells. Binding marks or blocks a target but is not always direct killing; distinguish recognition, effector action and phagocytic removal.
Clonal selection activates only lymphocytes with receptors complementary to the presented antigen. Mitosis produces genetically identical clones, which differentiate into effector cells for the current response and memory cells for a faster secondary response.
| Cell type | Main role |
|---|---|
| B effector/plasma cell | Secretes large quantities of antigen-specific antibody |
| B memory cell | Persists and rapidly forms plasma cells after re-exposure |
| T helper cell | Releases cytokines that activate B cells, macrophages and other T cells |
| T killer cell | Recognises antigen on infected or abnormal body cells and triggers their death, including with perforin-mediated damage |
| T memory cell | Persists and generates a faster cell-mediated response on re-exposure |
An antigen-presenting macrophage can activate T helper cells. Helper cytokines support both the humoral B-cell response and cell-mediated T-cell response, so the cell types cooperate without performing interchangeable jobs.
T helper cells do not secrete antibodies, and B cells do not kill infected body cells directly. Memory cells provide readiness; they are not continuously secreting maximum antibody amounts.
Active immunity follows exposure to an antigen and creates memory cells. It can be natural after infection or artificial after vaccination. Passive immunity transfers antibodies from another source and does not create memory.
Active responses are slower initially but usually longer-lasting; passive protection is immediate but temporary. Vaccination presents antigen without needing the disease itself to establish memory.
Antibodies crossing the placenta are natural passive immunity, while a vaccine is artificial active immunity. An antitoxin injection gives passive antibodies and may need repeating.
Antibody presence does not prove active immunity. A vaccine may need updating when pathogen antigens change, and passive antibodies do not train a secondary response.
An evolutionary arms race occurs when pathogen variants that evade immunity reproduce more successfully while host defences favour recognition and removal. The changing pathogen and host populations create reciprocal selection pressures.
HIV can vary its antigens, kill helper T cells and reduce antigen presentation; Mycobacterium tuberculosis can interfere with lysosome fusion and persistence inside phagocytes.
Memory cells against one viral strain may not recognise a mutated antigen, so the host faces a new primary-like response while the new strain spreads.
Co-evolution does not mean every mutation is advantageous or that immunity disappears completely. Identify the evasion mechanism and the selection consequence.
A bacteriostatic antibiotic prevents bacterial growth and division while exposure is maintained, leaving immune defences to clear the population. A bactericidal antibiotic causes bacterial death. The classification depends on the organism, drug concentration and test conditions, so it describes an observed effect rather than a permanent label in every context.
| Effect | Culture observation | Clinical implication |
|---|---|---|
| Bacteriostatic | Cell number or turbidity stops increasing; viable cells may regrow after drug removal | Relies more on host clearance |
| Bactericidal | Viable count falls and cells do not regrow after removal under the test conditions | Useful when rapid killing is required |
Selective toxicity arises because drugs target bacterial features such as murein-wall synthesis, 70S ribosomes or bacterial DNA-processing enzymes. Viruses lack these bacterial targets, and host toxicity must still be assessed.
No visible growth during treatment does not prove every bacterium is dead. Test viability after removing the drug, and do not use the static/cidal distinction to claim that antibiotics treat viral infection.
To compare antibiotics, spread a known bacterial culture on sterile agar, place equal-sized antibiotic discs and measure the clear zones after the same incubation. A larger zone suggests greater inhibition under those conditions.
Use aseptic technique, a distilled-water negative control, equal disc size and concentration where possible, replicate plates and consistent incubation. Invert plates to reduce condensation and use safe temperature/containment.
If tetracycline produces a 14 mm zone and methicillin 8 mm on the same strain, tetracycline inhibited growth more in that assay; the result does not automatically establish clinical choice.
Zone diameter depends on diffusion, concentration, agar and bacterial growth rate, not only antibiotic potency. Do not compare zones from different protocols without calibration.
Hospital-acquired infection risk is reduced by interrupting transmission: identify the pathogen and reservoir, clean or sterilise equipment, isolate cases, use hand hygiene and protect vulnerable patients.
Different controls act on different links. A disinfectant reduces environmental load, aseptic technique prevents transfer during procedures, and antibiotic stewardship reduces selection for resistant strains.
A catheter-associated infection needs both sterile insertion and ongoing site care; treating only the patient after symptoms appear leaves the route of transmission unchanged.
“Sterile” equipment and “clean” surfaces are not interchangeable, and an infection-control measure is not automatically effective without compliance and monitoring.
Bacteria and fungi secrete enzymes that digest large molecules in dead tissue into smaller molecules. They absorb and respire these products, releasing carbon dioxide and sometimes methane.
Decomposition returns carbon to the atmosphere and leaves nutrients available for reuse. Oxygen availability changes the pathway and the gases produced.
In an aerobic compost heap, decomposers release carbon dioxide while breaking down plant material; an anaerobic saturated site can produce methane instead.
Decomposers do not “destroy” carbon; they transfer it between organic matter, gases and soil. Gas output depends on conditions, not a fixed single product.
PCR copies a selected DNA sequence in vitro. Primers define the region, heat separates strands, primers anneal at a lower temperature and thermostable DNA polymerase extends complementary strands.
Each cycle can double the target, so a tiny starting sample becomes enough for profiling or analysis. The polymerase must survive the high denaturation temperature.
A 20-cycle run can produce roughly a million copies from a single target molecule under ideal doubling; a missing primer or wrong annealing condition prevents selective amplification.
PCR amplifies the chosen region; it does not identify a person by itself. Contamination can be amplified too, so controls and the target sequence matter.
DNA is negatively charged, so an electric field moves it toward the positive electrode. In an agarose gel, smaller fragments pass through pores more easily and travel farther than larger fragments.
Load samples with a known DNA standard, keep the polarity correct, run the gel consistently and compare band positions. A stain or fluorescent tag makes fragments visible.
A sample band aligning with the same-size standard indicates similar fragment length. A matching pattern across several markers is stronger evidence than one shared band.
Bands show fragment lengths, not whole-genome identity by themselves. Smearing, wrong polarity or overloaded wells can make a pattern unreliable.
A DNA profile compares variable DNA regions. DNA is extracted, selected loci are amplified by PCR, fragments or alleles are separated or detected, and the resulting pattern is compared with reference samples using the same markers.
For identification, agreement at several independent variable loci makes a common source more likely. The evidential strength depends on the combined profile frequency, sample quality, contamination controls and chain of custody; a profile match is not by itself proof of an event or guilt.
For parentage or relatedness, each offspring allele should be explainable by its parents. Across plants or animals, more shared profile markers generally support a closer genetic relationship, provided homologous loci and suitable reference populations are compared. Profiles can also distinguish cultivars, individuals or breeding lines.
One shared band is weak evidence, and band position alone does not reveal a whole genome. Identical twins, mixed samples, mutation, contamination and population structure can limit interpretation.
Time since death is estimated as an interval by combining independent indicators. Each indicator has a temperature- and environment-dependent rate, so investigators record scene conditions and avoid treating one observation as an exact clock.
| Indicator | Time-linked change | Major limits |
|---|---|---|
| Body temperature | Core temperature approaches ambient temperature | Clothing, body size, airflow, contact surface and changing ambient temperature |
| Muscle contraction | Rigor mortis develops as ATP is depleted, then fades as proteins decompose | Initial activity, temperature and disease alter timing |
| Decomposition | Colour, bloating, tissue breakdown and mass loss progress | Temperature, moisture, oxygen, burial and scavengers |
| Ecological succession | Predictable decomposer and scavenger communities replace one another | Habitat, access and season change the sequence |
| Forensic entomology | Insect species and egg/larval/pupal stage indicate accumulated development | Colonisation delay and development temperature must be known |
Measure core and ambient temperature, record rigor distribution and decomposition stage, collect insects from several body locations and preserve some while rearing others for identification. Use species-specific temperature-development data, then compare the resulting intervals with scene and succession evidence.
Body cooling is not linear indefinitely, and insect age estimates time since colonisation, which may be later than death. Report assumptions and the overlapping interval supported by several indicators.